What can we expect from first-generation COVID-19 vaccines?

Lancet. 2020 Nov 7;396(10261):1467-1469. doi: 10.1016/S0140-6736(20)31976-0. Epub 2020 Sep 21.

Authors

Malik Peiris¹, Gabriel M Leung²

Affiliations

¹ School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
² School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China. Electronic address: gmleung@hku.hk.

No abstract available

MeSH terms

Betacoronavirus*
COVID-19
COVID-19 Vaccines
Coronavirus Infections / epidemiology
Coronavirus Infections / prevention & control*
Coronavirus Infections / transmission
Humans
Pandemics / prevention & control*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / transmission
SARS-CoV-2
Viral Vaccines*

Substances

COVID-19 Vaccines
Viral Vaccines